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ABSTRACT  
   
There is a gap between today’s scientific advances and their application—between 
what is known and what is actually being done. This gap occurs because of the process of 
knowledge translation required to digest research findings for policymakers and 
practitioners. Studies have repeatedly shown that because of this “know-do” gap, 
approximately one-half of patients in the United States and Europe are not receiving care 
according to the most recent scientific evidence. Children are a medically unique and 
underserved population that stands to be most affected by this gap. Therefore, in this study, 
the research-practice gap in the pediatric field was calculated and discussed in the context of 
knowledge brokers, who facilitate opportunities for knowledge translation. Article mentions 
from the journal Pediatrics were identified in policy documents and analyzed for the years 
2010, 2013, and 2016 with the use of the Altmetric platform as a quantitative means of 
identifying patterns and drawing conclusions about the knowledge translation gap in 
pediatrics. Altmetric is a bibliometric tool that offers viable insights into the types of impact 
not covered with traditional methods of citation analysis. The expert policymaking bodies 
that cited the Pediatrics articles in their policy documents were coded, categorized, and 
subcategorized to clarify how and where Pediatrics research is ultimately being used to create 
health policy and to discover whether the gap is similar or different between the various 
types of policymaking organizations. This allowed the quantitative findings to be nested 
within a qualitative context. It took a mean of 7.1 years for research to reach the point of 
policy uptake for practitioners, with a range of 0-32.8 years. There were more international 
policy mentions than U.S. mentions, but information made its way through the knowledge 
translation process more quickly in the United States than it did elsewhere. In fact, nearly 
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40% of articles were cited in policy fewer than five years after original publication. The gap 
in pediatrics is thus significantly shorter than the 17-year average reported in the literature. 
However, knowledge brokerage activities performed by technical communicators are 
continually needed to build links between research, policy applications, and practice. 
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CHAPTER 1 
INTRODUCTION 
In medicine, researchers and practitioners operate in different worlds, with different needs, 
goals, cultures, timelines, and rewards (Kothari & Wathen, 2013). The professional, cultural, 
and linguistic gap between these two worlds has been well documented (UNICEF, 2008; 
World Health Organization, 2004; U.S. Department for Health & Human Services, 2001). 
The synthesis of biomedical research findings into practice occurs through the process of 
knowledge translation, led by knowledge brokers, who tackle the thorny problem of how to use 
research to strategically cross disciplinary boundaries (Holmes, McDonald, Jones, & 
Graham, 2016).  
 
In medicine, each field of inquiry has complementary—albeit unique—translation goals 
(Teachman et al, 2012). Despite many reports in the literature on the research-practice gap in 
biomedicine, the gap for individual subspecialties has not been defined to date, to my 
knowledge; additionally, I could not find reports of the gap being previously defined in the 
field of pediatrics. Because the pediatric population is unique and stands to be greatly 
affected by this gap, I chose the field of pediatrics, and the exploration of the specific 
research-practice gap within it, as the basis for my study. 
 
The purpose of this thesis was therefore to define the gap between the publication of 
original research in the peer-reviewed journal Pediatrics and its eventual use in policy and 
practice. I sought to elucidate whether there is (a) a single, consistent gap, by studying 
mentions of Pediatric articles in sample years of policy documents generated by a wide variety 
of policymaking organizations, or whether (b) the gap varies from year to year and according 
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to policymaking organization types and locations. In this way, I was able to pinpoint what 
the research-to-practice gap in pediatrics actually looks like, instead of what it may or may 
not be assumed to be in the broader biomedical literature. 
 
The research questions I investigated were as follows: 
 
What is the specific knowledge translation gap between original research publication in 
the journal Pediatrics and its eventual uptake in policy? 
Is this knowledge translation gap the same between sample years of policy, or is it 
variable? 
Are there differences or no differences in this gap among the various policymaking 
organizations that use Pediatrics research evidence? 
 
In my review of the literature, I investigated each interlocking piece of this particular puzzle: 
the historical “know-do” gap in biomedicine, the knowledge translation process and the role 
of knowledge brokers within it, the field of pediatrics and why investigating the knowledge 
translation gap within it is important, the appropriate methods used for determining current 
research impact, and the crucial role policy plays in the uptake and dissemination of research 
evidence for practitioners. 
 
The altmetrics (“alternative metrics”) approach was identified as a research vehicle 
appropriate for use in this study because it offers readily available insights into types of 
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impact not achievable with traditional methods. While altmetrics has been employed to study 
a number of individual biomedical subspecialties previously, including emergency medicine 
(Barbic, Tubman, Lam, & Barbic, 2016; Trueger et al, 2015) and orthopedics (Scarlat, 
Mavrogenis, Pecina, & Niculescu, 2015), I was not able to identify studies involving its use in 
pediatrics—or its application in exploring the know-do gap within any individual biomedical 
subspecialty. I therefore saw an opportunity to build upon the existing literature, while 
describing something previously unknown in this particular sector of technical 
communications. 
 
The results I was able to generate with the Altmetric platform allowed me to define and 
characterize the research-practice gap in pediatrics, both qualitatively and quantitatively. 
They also enabled me to consider what my findings within the field of pediatrics represent in 
the greater context of biomedical reporting, how they relate to what has been reported 
previously in the literature, and what they add to the existing technical communications 
knowledge base. 
 
The goal of this research was therefore to use the altmetrics method to define the knowledge 
translation gap between original research published in the journal Pediatrics and the eventual 
use of this research to enact health care policy for pediatricians and other practitioners. By 
defining the gap in this critical field of medicine, my findings not only supplement our 
working knowledge as technical communicators and knowledge brokers, but they may help 
to transform the way we approach knowledge brokering as communications experts in 
science. 
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CHAPTER 2 
LITERATURE REVIEW 
In laying the groundwork for answering my research questions, an in-depth review of the 
literature was required for the following individual pieces: the “know-do” gap in 
biomedicine, the knowledge translation process and the role of knowledge brokers within it, 
the field of pediatrics and why investigating the knowledge translation gap within it matters, 
the appropriate methods used to determine current research impact, and the vital role policy 
plays in the uptake and dissemination of research evidence for practitioners. Herein, I’ve 
summarized the literature for each piece. 
 
The “Know-Do” Gap 
The Disconnect Between Science and Its Application 
Researchers advance science by adding to the knowledge base—they produce evidence, which 
policymakers and practitioners use for decision making. The goals of researchers are 
therefore “publications, patents, and professorships” (Pang, 2003). However, because 
researchers tend to be less interested in the big-picture policy or practice aspects of their 
work, their findings often require “translation” before they can be understood and used by 
policymakers and practitioners (UNICEF, 2008). Indeed, it has been said that researchers 
and policymakers do not speak the same language; researchers are from Mars, and 
policymakers are from Venus (Feldman, Nadash, & Gursen, 2001). 
 
Practitioners and policymakers, on the other hand, are interested in solutions that can be 
applied to a broad swathe of people and issues (Choi et al, 2005). Medical practitioners work 
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in many contexts, including clinical, regulatory, administrative, community, and educational 
environments (World Health Organization, 2004). Policymakers are a heterogeneous group 
of individuals with varying levels of experience and expertise—including legislators 
(generalists who make decisions about funding), administrators (specialists with strong 
research backgrounds), and other representatives tasked with solving problems. The targets 
in this world are “policy, practice, and people” (Pang, 2003).  
 
From policymakers’ and practitioners’ perspectives, most research is pointless and has no 
real-world value—a view that has been substantiated by a number of reports in the literature 
(Ioannidis, 2016; MacLeod et al, 2014). Information in research publications tends to be 
dense, with the findings buried in the text. Policymakers want a “bottom line,” but 
researchers are often uncomfortable providing one, since they tend to focus on issues not 
directly related to policy or practice applications. This creates significant challenges in 
bridging the divide between knowledge and action. 
 
The processes through which knowledge is exchanged, translated, and synthesized are 
complex. In the world of policy and practice, research knowledge must often compete with 
factors such as cultures, habits, traditions, political considerations, personal interests, beliefs, 
intuition, and superstitions (World Health Organization, 2004). Research can improve the 
robustness of decision-making; the scientific literature helps to widen the sphere of influence 
on policy. The trick is therefore to connect science with policy (Choi et al, 2005). However, 
science can be a slow-moving process, since it builds upon previous research findings. 
Dramatic breakthroughs are rare; as a rule, good science is cumulative and generalizable 
(Huston, 2008). For this reason, it can be relatively unhelpful from a policy perspective. 
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Policymakers have very little time to consider original scientific publications—and yet, the 
policies, guidelines, and regulations they create have a profound effect on our daily lives and 
health status (Brownson, Royer, Ewing, & McBride, 2006). 
 
The Gap Affects Patient Care 
If research findings are not effectively “translated” for use in policy and practice, there can 
be a wide gulf between what is known from research evidence and what is actually done in 
practice (Davis et al, 2003). Because of this gulf, effective drugs, services, and programs 
often do not reach the patients who need them; healthcare systems can incur unnecessary 
expenditures; and patients can be exposed to unnecessary harms (Grimshaw et al, 2012). For 
example, there has been widespread variation in the use of aspirin, ß-blockers, anti-ischemic 
drugs, and calcium antagonists in the United States, Europe, and Canada, despite good 
evidence on their best use (Davis et al, 2003).  
 
Multiple studies have shown that patients receive a dismal 55% of recommended care 
because they are not benefiting from recent advances, and the quality of their treatment 
varies (McGlynn et al, 2003; Novak et al, 2011; U.S. Department for Health & Human 
Services, 2001). Additionally, 20% to 30% of patients may receive treatment that is not 
needed or is potentially harmful (Grimshaw et al, 2012; Novak et al, 2011). Novak et al 
(2011) point out that while health professionals ideologically support evidence-based 
practice, this does not necessarily translate into the provision of patient care. Ward et al 
(2009) argue that in healthcare, failing to translate research evidence into action contributes 
to health inequities and causes costly and time-consuming research to be wasted.  
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Research Versus Real-World Concerns 
With so much valuable medical research available today, what causes it to go unused?  For 
one thing, research favors the generation of new knowledge, over the assimilation of what is 
already known. Additionally, many features of academic culture can render the information 
produced by researchers unsuitable for use in policymaking and practice. Practitioners 
complain that researchers are not creating interventions that they can apply effectively 
(Teachman et al, 2012). Lewis (2007) maintains that “A great deal of scientific inquiry and 
reporting has little or no concern for indirect effects or the context within which phenomena 
occur.” Researchers write for other researchers (Feldman, Nadash, & Gursen, 2001); for 
uptake by practitioners, however, research findings must be distilled into policy-relevant 
terms or otherwise disseminated more widely—but there can be few resources available to 
do this. Relying on journals and guidelines for dissemination places the responsibility on the 
practitioner to read, accurately interpret, and effectively apply the findings in his or her own 
setting (Olswang & Prelock, 2015), which can lead to wide variation in interpretations and 
applications. 
 
Many researchers lack the specific skills and tools required for knowledge translation and 
may need significant support to make their work more readily available to policymakers and 
practitioners (Feldman, Nadash, & Gursen, 2001). Indeed, some practitioners have concerns 
about whether researchers are even receptive to research about clinical outcomes (Teachman 
et al, 2012). Practitioners describe problems they’ve encountered in implementing empirically 
supported treatments, because most treatment research samples do not reflect the 
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demographics or clinical presentation of the general population (Dingfelder & Mandell, 
2011). DeAngelis (2010) bemoans the “cherry picking” of patients for research purposes, 
which does not always translate to the “messy, real-world” of patients seen in clinical 
practice. As Lewis (2007) points out, “The randomized controlled trial is an artifice; it does 
not occur in nature.” There is a general feeling discussed by Chambless and Ollendick (2001) 
that intervention studies can be categorically ignored by practitioners, because research 
reflects the singular interests of a few biased researchers and does not translate into “real-
world practice.”  
 
A tenet that is often overlooked in the pursuit of research evidence is that knowledge 
depends as much on the evaluation of existing research as it does on the generation of new 
research. In the past, this neglect has led to inefficient use of limited resources for research 
and missed opportunities for achieving gains in health (World Health Organization, 2004). 
Brownson et al (2006) argue that researchers are obligated not only to discover new 
knowledge, but also to ensure that current discoveries are applied to improve patient health 
and well-being. New research should build on existing knowledge, and health decision 
makers should use research syntheses to inform policy and practice; failure to do so may 
result in serious consequences for patients and inefficient expenditure of limited healthcare 
resources (World Health Organization, 2004). In this context, understanding how policy and 
practice develop has the potential to facilitate a more effective use of research evidence 
(Haworth-Brockman, 2016; Deas, Mattu, & Gnich, 2013).  
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Policymakers have unique needs of their own—they require help in navigating the profuse 
but fragmented information sources available to them. The task of sifting through 
mountains of undigested information is a time-consuming and perplexing one, and research 
studies—especially in the medical sciences—often yield conflicting results (Joseph, 2013). 
Policymakers complain that information is generally too dense and copious, creating 
difficulties for them in picking out relevant or even useful information (Feldman, Nadash, & 
Gursen, 2001). As Lewis (2007) puts it, “Few will embark on a lengthy treasure hunt to 
chase down the parts and assemble them into a whole.” Policymakers maintain that their use 
of research-based information is largely contingent on its conversion into simple and 
understandable terms that make it relevant to the problems they face and enable them to 
persuade others of its significance (Feldman, Nadash, & Gursen, 2001). These needs 
highlight the importance of translation (conversion) and synthesis (amalgamation)—activities 
needed to digest evidence-based information, to help policymakers slice through the 
overabundance of information and interpret its meaning for policy formulation and 
incorporation into practice. 
 
McNatt et al (2010) discovered that 42% of research articles do not discuss implications for 
practice, which is a staggering amount of research that potentially does not translate to the 
practice environment. They assert that although the gap may never be closed, with better 
efforts, it may certainly be narrowed. The central challenge for evidence-based policy is to 
develop more rigorous, systematic, and global methods for identifying, interpreting, and 
applying evidence in decision-making contexts (Dobrow, Goel, Lemieux-Charles, & Black, 
2006). 
 
  10 
 
There are already a number of initiatives dedicated to bridging this gap in healthcare, such as 
the U.S. Agency for Healthcare Research and Quality, the Cochrane Collaboration’s 
Effective Practice and Organization of Care Group, and The National Institute for Health 
and Care Excellence in the United Kingdom. Teachman et al (2012) indicate that if 
researchers asked how they could make ongoing outcome assessment feasible for 
practitioners and assisted with translating efficacy research into clinical practice, then 
multiple levels of translation could be invoked, to better implement a two-way bridge 
between research and practice. Kadzin (2008) says that with better communication and 
connection, both “sides” of the gap can win, because collaboration will not only foster 
improved clinical care but will also serve to develop and strengthen the existing knowledge 
base.  
 
Knowledge Translation as Digestion 
Knowledge translation constitutes the deliberate intention to digest research findings for 
practical application (Haworth-Brockman, 2016). Although the concept has been around for 
more than 100 years, in the 1990s, the Canadian Institutes of Health Research (CIHR) 
published a landmark report in which they defined knowledge translation as “a dynamic and 
iterative process that includes the synthesis, dissemination, exchange, and ethically-sound 
application of knowledge to…provide more effective health services and products, and 
strengthen the healthcare system” (Canadian Institutes of Health Research, 2017; Joseph, 
2013). With this report, a deliberate strategy was adopted to encourage clinical and other 
health researchers to consider and convey how their studies could be beneficial and how 
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their results might be adapted in practice settings. Explicitly linking research to practice was 
deemed essential—and it continues to be (Haworth-Brockman, 2016).  
 
The process of knowledge translation in biomedicine can be notoriously slow and haphazard 
(Graham et al, 2006), with research averaging 17 years to reach policy and practice (Green, 
Ottoson, García, & Hiatt, 2009) and often taking 20 years (Clancy, Glied, & Lurie, 2012; U.S. 
Department for Health & Human Services, 2001; Dingfelder & Mandell, 2011). This can be 
problematic because failing to seize upon accessible evidence may delay critical medical 
interventions or perpetuate the use of suboptimal ones. For example, it took nearly 20 years 
to effect serious policy changes after publication of the Harvard Medical Practice Study on 
medical errors (Clancy, Glied, & Lurie, 2012). However, the methods used to define the gap 
in these reports were not clearly elucidated, which creates a somewhat nebulous picture of 
how the research-practice gap has been defined previously. For knowledge brokers to be 
able to assist in bridging the gap, more precise information is needed. Indeed, only by more 
fully understanding these processes can we begin to ensure better use of appropriate 
knowledge, so that interventions are as effective as possible (Deas, Mattu, & Gnich, 2013). 
 
The medical community has realized that medical practice covers much more than the 
application of biomedical science to patient care and is thus being transformed by 
“translational medicine,” which is attempting to bridge the gap between medical researchers 
and care providers (Jackson, Garfin, & Enquist, 2017). In the biomedical realm, when we 
discuss knowledge translation, knowledge is shorthand for evidence—which has been 
understood to mean empirically derived results (Haworth-Brockman, 2016).  
 
  12 
 
When the CIHR developed its knowledge translation requirements, the intent was to 
promote evidence-based practice and the use of research in practice (Haworth-Brockman, 
2016). The focus was on encouraging interaction among the producers and users of research, 
removing the barriers to research use, and tailoring information to different target audiences 
so that effective interventions are used more widely. In medicine especially, knowledge 
translation is a critical undertaking because poorly translated information is often not used 
(Feldman, Nadash, & Gursen, 2001), leading to wasted research and resources.  
 
Undigested findings from individual studies ideally undergo replication 
(reproduction/validation) and synthesis, processes that help “digest” them for uptake in policy 
and practice (Ioannidis, 2006). Therefore, the cumulative evidence that results is what 
ultimately becomes part of the accepted knowledge base. As such, knowledge management is 
becoming an important strategy to ensure that any knowledge produced is actually used to 
improve health. This term refers to not only the body of knowledge, but also how this 
knowledge is systematically accessed, collected, archived, disseminated, synthesized, and 
used. In addition to the well-known use of biomedical knowledge to develop drugs, vaccines, 
diagnostics, devices, and other interventions, knowledge management also includes the utilization 
of knowledge to inform policy, practice, and public opinion (World Health Organization, 
2004). The processes and desired outcomes of knowledge management affect not only 
decision makers (who establish health policy), but governments and funding bodies, as 
well (Haworth-Brockman, 2016). 
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Many people view the knowledge translation model as the most promising way to bridge the 
gap between the care people should be receiving and the care they actually receive (World 
Health Organization, 2004). However, knowledge translation funnels and diagrams are 
typically one-way affairs (Green, Ottoson, García, & Hiatt, 2009; Graham et al, 2006; 
Pronovost, Berenholtz, & Needham, 2008). In the center of the standard knowledge 
translation model is a funnel, where knowledge “flows” in stages, from initial inquiry, to 
synthesis of multiple knowledge sources, to particular tools or resources developed for 
specific audiences (Haworth-Brockman, 2016). Westen et al (2004) believe that too much 
emphasis is placed on the “flow” of knowledge from researchers to practitioners, creating a 
unidirectional model of science and practice. With this model, researchers express frustration 
because their basic science and RCT findings are not being implemented in everyday practice 
(Teachman et al, 2012). Thus, this unidirectional approach has been shown to be less 
effective than a more circular method, where researchers get feedback and input from 
practitioners, policymakers, and patients. There is a need for a more bidirectional model, but 
the knowledge translation process is skill-intensive, time-consuming, fluid, and variable, 
which makes it impossible to use a one-size-fits-all approach. In other words, there is no one 
model that can be applied to all situations (Deas, Mattu, & Gnich, 2013; Lavis et al, 2003). 
 
In reality, the process of knowledge translation is messy and complicated, and the problem 
of making evidence or knowledge in any of its forms available for practical application is a 
pervasive one (Haworth-Brockman, 2016). Knowledge translation requires a shift in 
thinking, from the idea of research findings being meritorious in their own right to 
packaging knowledge as a commodity to be used for application (Phillipson, 2014). Within 
this strategy, the digestion (condensation) of the research findings is key. Findings must be 
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presented in clear language that is free of research jargon, and researchers must think 
through and unambiguously articulate the policy implications of their work (Feldman, 
Nadash, & Gursen, 2001). This is where knowledge brokers come into play. 
 
Knowledge Brokers 
Knowledge brokers are organizations and individuals who translate and disseminate research 
findings in an accessible format for use in policymaking and practice. They essentially act as 
intermediaries between the worlds of research and action (Grimshaw et al, 2012). Conklin et 
al (2013) define knowledge brokers as those who engage in analytical, technical, and relational 
activities to foster the development and operation of practice communities—a vital task 
often performed by professional communicators or other intermediaries.  
 
In effect, knowledge brokers serve as “middle men,” by simplifying and combining 
information in ways that make it more transparent and understandable. They provide 
policymakers and practitioners with accurate and reliable digested information, to allow 
quality decisions to be made on the basis of quality information. This is a very important 
step of the process, for which research funding usually does not provide (Choi et al, 2005). 
Like knowledge translation itself, Conklin and colleagues (2013) maintain that the role of the 
knowledge broker is perhaps not yet fully understood.  
 
Berta et al (2010) found that the ability to apply knowledge to practice is dependent on the 
ability of institutions and organizations to facilitate the adoption of new information. Thus, a 
knowledge broker engages with knowledge producers and end-users to identify issues that 
require solutions. The broker also brings producers and users together to determine shared 
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goals, as well as mutual understandings of language, opportunities, and constraints (Dobbins 
et al, 2009). Many policymakers rely on knowledge brokers to assemble and package research 
findings for them, to create bite-sized bundles of information they can use. Brokers facilitate 
this exchange of knowledge to help policymakers develop needed health solutions 
(Haworth-Brockman, 2016).  
 
When dealing with information overload, it is increasingly important to foster effective and 
scientifically sound brokerage activities. Policymakers estimate that 49% of the information 
they receive is not relevant to their current work (Sorian & Baugh, 2002). It can be difficult 
to communicate complex, evidence-based information to policymakers, who are already 
awash in information and who have to wade through masses of information and make sense 
of it (Feldman, Nadash, & Gursen, 2001). Therefore, to maximize policy uptake, scholars 
who work on the research-policy interface advise sticking close to the data, using value-
neutral language, and not making unwarranted leaps from data to advocating particular 
policies. Knowledge brokering organizations can also become trustworthy to policymakers if 
they are seen as objective and evenhanded (Huston, 2008). 
 
Some organizations, such as the American Academy of Pediatrics, have developed their own 
information brokering capacity. A number of membership organizations that represent 
policymakers include brokering activities among their services to focus on topics important 
to their constituents (Feldman, Nadash, & Gursen, 2001). Brokerage entities include 
advocacy organizations, government agencies, university research centers, for-profit and 
nonprofit research centers, bridging organizations, constituent organizations, and 
foundations (Feldman, Nadash, & Gursen, 2001). Subject areas undertaken for translation 
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can reflect the membership, the brokers’ established areas of expertise, and the 
organizational goals. 
 
Information brokerages such as the American Academy of Pediatrics are often independent 
bridging organizations that link the two distinct worlds of research production and 
policymaking (Feldman, Nadash, & Gursen, 2001). Bridging organizations focus on 
identifying important policy issues and conveying policy-relevant information. They often 
work through committees of policymakers to identify key issues and needs. Some cultivate 
their own in-house staff of technical communicators to synthesize and translate existing 
research or assist in policy-related activities. By effectively translating the huge amount of 
research being conducted into usable outcomes, knowledge brokers can nurture and build 
relationships among individuals within and among organizations who have different types of 
knowledge (World Health Organization, 2004), thereby promoting maximum benefit for all 
stakeholders. 
 
The Gap in Pediatrics 
Children are Unique 
Children are a medically unique and chronically underserved population in medicine 
(Children and Clinical Studies, 2018; Dingfelder & Mandell, 2011; World Health 
Organization, 2004; Huston, 2008). Pediatric patients in various age groups respond 
differently to care—a 7-month-old is different than a 7-year-old, who is different than a 17-
year-old. At each stage of growth, children need different doses of medicine, different types 
of treatments, and differently sized medical devices (Children and Clinical Studies, 2018). 
Studies must therefore be conducted in children of all ages to ensure maximum effectiveness 
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of interventions.  
 
Historically, huge gaps existed between best evidence and practice in the implementation of 
clinical practice guidelines (Davis et al, 2003). For this reason, the U.S. Agency for 
Healthcare Research and Quality rolled out their Translating Research Into Practice (TRIP) 
initiatives (U.S. Agency for Healthcare Research and Quality, 2017) to assist in the 
translation of research findings into clinical practice. Notably, six of the primary projects 
undertaken by TRIP were pediatric in focus. These projects included pediatric asthma 
management, Head Start, preterm infant care, tobacco cessation programs affecting the 
pediatric population, and adolescent concerns (U.S. Agency for Healthcare Research and 
Quality, 2001). Because of such initiatives, the spread of Early Intervention childhood 
development programs is an example of strong, cumulative evidence that contributed to a 
policy consensus (Huston, 2008).  
 
However, knowledge that an intervention works is only half of the equation. The Bellatio 
Study Group on Child Survival (2003) states that what truly stands in the way of improved 
pediatric health is knowing how to effectively implement and use an intervention. A health 
system is therefore much more than a vehicle to deliver the products of research; it also 
contains a wealth of knowledge that must be tapped to be able to complete the second half 
of the equation (World Health Organization, 2004). However, Tenopir et al (2007) found 
that two-thirds of office-based pediatric practitioners deemed the volume of medical 
literature to be “unmanageable” and bemoaned the amount of “irrelevant” material they 
have to cull through to be able to find what they need. For this reason, evidence-based 
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therapies—some of which could prevent morbidity or death—often do not get translated 
into real-world clinical practice (Pronovost, Berenholtz, & Needham, 2008).  
 
Children Are Underserved 
Policymakers and practitioners are constantly faced with the reality that a significant portion 
of the pediatric population is underserved by healthcare initiatives. In the United States 
alone, one-quarter of all children under the age of six live in poverty, and half of this group 
lives in extreme poverty. Additionally, large numbers of children are affected by at least one 
risk factor associated with poor health and academic failure (Schmit, Matthews, Smith, & 
Robbins, 2013). The increasing prevalence of pediatric obesity, for example, is highest for 
minority children and adolescents from economically disadvantaged families (Jelalian, 
Wember, Bungeroth, & Birmaher, 2007). In low-income settings in particular, evidence-
based practice is particularly important, because limited resources must not be wasted 
(World Health Organization, 2004). 
 
More than one in four children in the United States has a parent born outside the country, 
and young children of immigrants are less likely to have access to health care and early 
education. A complex mix of state and federal policies affects the access of low-income 
families to quality early child care and education; but currently, many of these policies do not 
benefit large numbers of young children who are experiencing economic hardship and other 
circumstances that seriously risk their healthy development and success in school. State 
policies on such matters (such as Head Start and child care subsidies) affect whether 
immigrant families are able to participate in and benefit from such programs (Schmit, 
Matthews, Smith, & Robbins, 2013). When creating these policies, all available information 
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must be weighed, including data on the magnitude of the problem, epidemiological data on 
determinants, stakeholder opinions on the nature of the problem and acceptable solutions, 
existing practices and traditions, less robust yet promising intervention analyses, program 
options within budgetary constraints, and legal considerations, such as privacy laws 
(Anderson et al, 2005).  
 
From a broader view, children are also underserved globally—this is not a problem exclusive 
to the United States. Each year, an estimated 15 million children—40,000 children per day—
die from infection and malnutrition (World Health Organization, 2004). In 2013, 5.9 million 
children died from easily preventable or treatable causes (American Academy of Pediatrics, 
2018); and nearly two-thirds of the deaths in children younger than five could be prevented 
by applying simple, cost-effective interventions (Bellagio Study Group on Child Survival, 
2003).  
 
In pediatric medicine, research dissemination efforts are often targeted at federal 
policymakers, but state and local administrators also make and oversee many policy decisions 
that affect children and families (Huston, 2008). Therefore, the issue of disseminating timely 
and effective information on interventions to policymakers at all levels is a critical one. 
Adding fatty acids to infant formulas, developing obesity and nutrition guidelines, 
supporting neurological development, and gauging cognitive development are all widespread 
pediatric healthcare issues affected by the research-practice gap.  
 
In the midst of these austere needs and challenges, the American Academy of Pediatrics 
functions as a primary knowledge brokerage organization in pediatrics, endeavoring to 
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bridge the gap between researchers, policymakers, and practitioners. It generates a wide array 
of dissemination materials for pediatric practitioners, including clinical and consumer books, 
patient education materials, and five peer-reviewed journals, as well as supporting 
policymaking and other federal and international advocacy efforts on the behalf of all 
children. I therefore selected Pediatrics, the flagship research journal of the Academy, for 
analysis in my study because it is a primary source of research evidence that supports 
policymaking and practice in the pediatric field. It is the most-cited journal in pediatric 
medicine and among the top 100 most-cited journals in all of science and medicine 
(American Academy of Pediatrics, 2018). 
 
Policy: The Meat of the Sandwich 
For medical practitioners, policy represents the mobilization of research-based knowledge 
into healthcare delivery. As such, the domains of policy and practice are inextricably 
intertwined. As Choi (2005) puts it, policy is the “meat” in the scientific sandwich, with 
science the “before and after” on either side. Jewell and Bero (2008) describe the necessity of 
incorporating high-quality research into compelling health policy to personalize and 
concretize its impact. For example, clinical practice guidelines are evidence-based policy 
guidelines that are distilled from research and used by practitioners to guide their approach 
to clinical practice. In this way, evidence-based health policy endeavors to establish best 
practice to ensure that patients receive optimum care, according to current evidence. 
 
However, researchers and policymakers are “like oil and water” (Greenlick, Goldberg, 
Lopes, & Tallon, 2005). Clancy et al (2012) observe that researchers and policymakers often 
seem locked in an unrequited love affair; each seeks the attention and respect of the other, 
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and yet each is endlessly frustrated. The challenges are substantial when successfully 
translating scientific evidence into appropriate and effective public policy, because 
researchers and policymakers have significantly different decision-making processes 
(Brownson, Royer, Ewing, & McBride, 2006). The process of tailoring information for use 
by policymakers is complex and has led to the development of synthesis methods for guiding 
policy and practice (Anderson et al, 2005). 
 
Policymakers’ decisions are affected by “The Four I’s:” ideology, interests, information, and 
institutional contexts (Huston, 2008). Science contributes to one of these areas—
information—in combination with other sources, such as expert opinion and common 
sense. Policymakers use research as a basis for general knowledge, as well as for choosing 
specific policy alternatives—especially when that information is scientifically sound and 
relevant to potential policy actions (Huston, 2008). 
 
There is a strong preference among policymakers for short, easy-to-digest information 
(Sorian & Baugh, 2002). The uptake of science into policy is more successful when findings 
are converted into unambiguous messages that are meaningful to policymakers and easy to 
apply (Berta et al, 2010). In medicine, multidisciplinary policymaking teams are tasked with 
developing lists of possible interventions; then, for each intervention, effectiveness studies 
are identified and assessed for quality. Main effects are summarized, characteristics that 
influenced effectiveness are described, barriers to implementation and unintended 
consequences are detailed, and costs are estimated. Finally, depending on the availability and 
strength of the evidence, the team recommends for or against an intervention or determines 
the evidence to be insufficient to draw conclusions (Anderson et al, 2005). 
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Policymakers report frustration with researchers’ unwillingness to clearly articulate the policy 
implications of their research, to “go out on a limb” and make policy recommendations 
based on their findings (Feldman, Nadash, & Gursen, 2001). Researchers’ reluctance to draw 
clear-cut conclusions is at odds with the demands of practitioners, who must make concrete 
decisions about which interventions to use (Dingfelder & Mandell, 2011). Ovretveit and 
Klazinga (2013) conclude that research could contribute more to national policy and local 
practice if researchers worked more closely with decision makers at all levels, took their 
questions more seriously, and used methods that can provide practical answers instead of 
theoretical ones, as well as improving the communication of their findings. Effective 
techniques for communicating research findings to decision makers include presenting 
readily understandable data in visually compelling formats, sending clear key messages about 
the meaning of data, and suggesting ways to use research findings for answering important 
policy questions (Feldman, Nadash, & Gursen, 2001). 
 
In medicine, the main users of research are medical staff, health system managers, health 
insurers, policymakers, patients, and other researchers (World Health Organization, 2004). 
As innovations are developed, it is crucial to evaluate them carefully so they can be added to 
the evidence base. When evidence is synthesized, many studies are combined to find 
consistencies in a set of findings (Anderson et al, 2005). However, there are few systematic 
reviews for interventions to evaluate the effects of knowledge translation strategies for 
policymakers (Grimshaw et al, 2012). What evaluations do exist have shown this process to 
result in the meaningful translation of scientific discoveries into policies (Brownson, Royer, 
Ewing, & McBride, 2006), because decisions are better informed by putting the best 
available evidence at the center of the policy process (UNICEF, 2008). Thus, the enactment 
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of policy is a shared responsibility between scientists and policymakers, because 
policymakers need quality information to be able to understand policy options and craft the 
most appropriate policy decisions (Brownson, Royer, Ewing, & McBride, 2006). 
 
Policymakers are tasked with allocating dollars, targeting services, and promoting efficiencies 
in delivery systems to expand access to high-quality health care. They must therefore focus 
on many factors besides research evidence, including budgetary considerations, regulations, 
court decisions, demographics, available service delivery systems, potential targeted 
interventions, and other legislation. Additionally, policymakers prefer to use information 
obtained directly from trusted sources, such as those with immediate knowledge of their 
circumstances, priorities, and needs. The substance of such information is generally 
perceived as more convincing and more readily applicable to current or anticipated policy 
problems than “undigested” information obtained from the academic literature (Feldman, 
Nadash, & Gursen, 2001). The findings of various information-producing activities should 
thus be synthesized and digested for use. 
 
According to the World Health Organization (2004), there is not enough evidence between 
health research and policy for systematic reviews to be able to reach definitive conclusions 
or establish what may be “best practices,” which is reflected in the fact that case studies are 
often used to establish links between the two. However, in lieu of case studies, there are 
exciting new resources being developed to be able to measure the impact of research on 
health policy (Bornmann, 2014). 
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Measuring Research Impact  
Since the 1970s, citation analyses have been used to determine the most influential authors 
and articles in a particular journal or field by examining the frequency of citations in articles 
and other texts (Barbic, Tubman, Lam, & Barbic, 2016). With traditional citation analysis, 
the evaluation of individual articles makes sense in the case of excellent reports, such as the 
top 5% of cited articles in a given field (Rasmussen & Andersen, 2013). In evaluating the 
impact of research, however, investigators at the Washington University School of Medicine 
discovered that (a) traditional citation analysis is not a sufficient tool for assessing the impact 
of research findings and that (b) results of citation analysis are not predictive of clinical 
applications that result in meaningful health outcomes (Sarli, Dubinsky, & Holmes, 2010). 
They maintain that knowledge transfer can be documented and quantified, but that it is not 
readily discoverable via standard citation analysis. In lieu of traditional citation analysis, the 
Washington University School of Medicine researchers developed “The Becker Model” of 
research impact (updated most recently in 2014), in which health policy is identified as a 
beneficial clinical implementation outcome to measure (Washington University School of 
Medicine, 2018).  
 
Scholarly publishing has entered a new era, in which new publication types are springing up 
from open science communities on the Internet. These are subsuming the role of the more 
traditional print journals (Patthi et al, 2017; Rasmussen & Andersen, 2013), for which 
citation analysis was developed. Citations are slow to accumulate; therefore, citation analyses 
rarely take into account new forms of scholarly content. In contrast, biomedical researchers, 
healthcare professionals, and patients are currently applying social media and new scholarly 
e-tools in broader ways, to facilitate and improve their knowledge and communication 
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(Patthi et al, 2017). This transition to digital dissemination is permitting access to a treasure 
trove of new metrics to track research impact (Thoma, Mohindra, Artz, & Chan, 2015), 
tailored to these new publication types and channels. Accordingly, the rise of online 
scholarly tools has led to the creation of new metrics for the impact of scholarly publications 
(Patthi et al, 2017). These new avenues have collectively been dubbed “altmetrics,” 
indicating their nature as alternatives to the established bibliometric methodology (Priem, 
Taraborelli, Groth, & Neylon, 2010; Rasmussen & Andersen, 2013). 
 
The premise of traditional citation analysis is that scientifically important articles are cited 
more frequently and that the number of citations indicate a direct measure of a research 
article’s impact on its scientific field (Barbic, Tubman, Lam, & Barbic, 2016). This is 
commonly measured with standard metrics, such as the h-index, Eigenfactor score, and 
Impact Factor. However, the Impact Factor is a measure that applies only to a journal as a 
whole, and not to a particular article (Kwok, 2013). Additionally, citation-based bibliometric 
standards such as these have been widely criticized of late (Barbic, Tubman, Lam, & Barbic, 
2016; Trueger et al, 2015). Citation analyses do not take into account the reasons for citation, 
nor do they consider the impact a research article has outside the realm of academia (Barbic, 
Tubman, Lam, & Barbic, 2016). Further, it can take years for citations to appear after the 
original article was published, which makes a real-time study of research impact virtually 
impossible. In peer-reviewed ophthalmologic journals, for instance, peak citations occurred 
three to four years after publication (Liu, Gai, Zhang, & Wang, 2015). In this setting of 
imperfect research impact estimation methods, Wouters and Costas (2012) have identified 
four benefits of altmetrics: broadness, diversity, speed, and openness. With altmetrics, 
impact data can be retrieved days to weeks after an article is published (Bornmann, 2014; 
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Citrome, 2015), thus providing a real-time analysis of research impact in a broader context 
than academia alone. 
 
Weighted Altmetric citations take policy mentions, Wikipedia content, scholarly blogs, 
Mendeley, Twitter, Facebook, and traditional news media sources into account (Altmetric, 
2017), to generate a quantitative Altmetric “score.” This allows the impact of an individual 
article to be compared numerically against other research studies. While traditional citation 
analysis provides a similar illustration, it does not follow that highly downloaded articles are 
also highly cited (Rasmussen & Andersen, 2013). In fact, Lin and Fenner (2013) revealed 
that only one person in 70 cites a paper they downloaded from the Public Library of Science. 
Thus, for the present study, I chose to isolate the policy-tracking capabilities of the Altmetric 
platform as a means of quantifying the gap in pediatrics research impact. 
 
Because the altmetrics method is an article-level measurement tool, it is now being used to 
track novel types of impact data. It provides a more complete picture of research impact by 
revealing scholarly activities other than the communication amongst researchers (Rasmussen 
& Andersen, 2013). The Altmetric score reveals the instantaneous scientific and public 
interest in a research paper (Patthi et al, 2017) and aims to address many of the failings of 
traditional impact metrics; Altmetric scores may provide more accurate assessments of total 
overall readership by incorporating more metrics than simply citations in traditional journals 
(Trueger et al, 2015). With recent technological advancements, millions of citations can now 
be evaluated for large-scale patterns and knowledge discovery (Barbic, Tubman, Lam, & 
Barbic, 2016), and our ability to discuss, download, and share material in real time and across 
the globe has grown exponentially (Rasmussen & Andersen, 2013). “Hidden impacts,” such 
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as effects on health policy and clinical practice, are now being revealed with the altmetrics 
paradigm (Bornmann, 2014). For this reason, Trueger et al (2015) propose that altmetrics be 
thought of as a measure of “disseminative impact.” With the widespread adoption of 
electronic publishing, dissemination of scientific outputs occurs across more channels than it 
did in the print age and happens faster than ever before (Melero, 2015). 
 
Altmetrics permit quantitative analyses of societal impact, which allows for the evaluation of a 
whole different side of research output than traditional analysis (Rasmussen & Andersen, 
2013). The purpose of the method is to provide an alternative, multidimensional view of 
impact (Priem, Piwowar, & Hemminger, 2012; Rasmussen & Andersen, 2013) by tapping 
different sources than were available previously (Rasmussen & Andersen, 2013)—including 
the assemblage of health policy data derived from research sources. The use of both 
traditional and altmetrics approaches to scientific knowledge dissemination may allow 
decision makers and stakeholders to determine which articles are deemed most important 
from a knowledge translation and synthesis perspective, by assessing traditional and 
nontraditional uptake of the literature (Barbic, Tubman, Lam, & Barbic, 2016).  
 
In this digital era, the evaluation of research output on both institutional and individual 
levels is becoming increasingly important (Vrkić, Škorić, & Petrak, 2017). Transparency is an 
important piece of the altmetrics equation on both of these levels, because it permits the 
identification and use of trustworthy indicators of research impact (Rasmussen & Andersen, 
2013), as well as transparent descriptions of the usage, reach, and interest of scholarly 
products (Bornmann, 2014). Altmetrics discourages “gaming,” or the manipulation of 
indicators, which is what bedevils the Impact Factor measure (Rasmussen & Andersen, 
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2013). Indeed, Gonzalez-Valiente et al (2016) refer to the Impact Factor as “already 
institutionalized,” because of the way it has been manipulated by research outlets. In 
contrast, multiple citations from the same source are not included in the Altmetric citation-
tracking system and thus cannot be factored into the weighted score more than once 
(Altmetric, 2017; Rasmussen & Andersen, 2013).  
 
Due to its versatility, its potential for pinpointing and studying multiple forms of research 
impact, its transparency, and its ability to meet the impact criteria laid out in the Becker 
model (Washington University School of Medicine, 2018), the Altmetric platform served as 
an ideal approach for me to be able to define the know-do gap for Pediatrics. 
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CHAPTER 3 
METHODS 
Since the American Academy of Pediatrics is a primary knowledge brokerage in the pediatric 
field, the decision to select its foremost research journal Pediatrics as a source for study was a 
natural one. Not only does Pediatrics publish research on every subspecialty within the 
pediatric field, but it also includes research for every age group, from prenatal care and 
newborns to adolescents and young adults, thereby representing a sufficiently broad patient 
population. It consequently has one of the highest impact factors of any pediatrics research 
journal indexed in the 2016 Thompson Reuters Journal Citation Report (American Academy 
of Pediatrics, 2018). 
 
The research questions I investigated were as follows: 
What is the specific knowledge translation gap between original research publication in 
the journal Pediatrics and its eventual uptake in policy? 
Is this knowledge translation gap the same between sample years of policy, or is it variable? 
Are there differences or no differences in this gap among the various policymaking 
organizations that use Pediatrics research evidence? 
 
Approach 
With the Altmetric tool, for every single use of an electronic resource, Altmetric records who 
used it, where, and when, as well as where the resource came from (Kurtz & Bollen, 2010) 
by using a centralized digital object identifier. Sources include citations, mentions, usage, 
captures, and social media (Melero, 2015). Instead of accessing citations of a paper in a 
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database, Altmetric.com uses a proprietary algorithm (Thoma, Mohindra, Artz, & Chan, 
2015) to measure article downloads, views, policy mentions, news coverage (with more 
weight given to news outlets such as The New York Times, as opposed to smaller publications; 
Citrome, 2015), book citations, discussions, and more across various platforms (Bornmann, 
2014). It can therefore readily be used to track policy mentions derived from articles 
published in the journal Pediatrics.  
 
The data available in the Altmetric system permitted the use of both quantitative and 
qualitative analyses. Since a quantitative research approach is used to determine the extent of 
a phenomenon, whereas a qualitative research method is applied to explore its nature 
(Kumar, 2014), I chose a mixed-methods approach, as it offers the attributes of both. I 
surmised that the combination approach would provide a better understanding of my 
research findings than either method could alone. Thus, a mixed-methods approach served 
as the basis for my Altmetric search. 
 
Data Collection 
To obtain a representative cross-section of the know-do gap in pediatrics and assemble a 
balanced sampling, I extracted mentions of Pediatrics articles in policy documents for three 
sample years. My intent was to obtain a variegated data set, while simultaneously keeping my 
findings as current (and therefore relevant) as possible. I selected policy documents from the 
years 2010, 2013, and 2016 for analysis. By building in a three-year lapse between samples, I 
aimed to avoid sampling too narrow of a window. I also wanted to ensure that the findings 
were somewhat spaced out, so that a true cross-section could be identified (ie, I avoided 
sampling consecutive years of data).  
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Within Altmetric Explorer, first I performed a general search for research outputs derived 
from the journal Pediatrics. The result of this search is provided in Figure 1. Note that the 
various output types are grouped in tabs along the top of the screen, with the proportions 
for each visually demonstrated along the bottom. The user can dive deeper into any 
particular type of research output by clicking on any of the 15 output tabs. 
 
 
Figure 1. The search return screen for research outputs from the journal Pediatrics.  
 
 
I isolated the policy outputs for further analysis by clicking on the “Policy” tab, which 
indicated that there were 4234 policy mentions for Pediatrics articles. Figure 2 provides an 
overview of the policy mentions available for study, broken out by years.  
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Figure 2. An overview of the policy data available for analysis, broken out by years. 
 
 
When the policy search results were further expanded, an itemized listing appeared for each 
policy document in the Altmetric database, including original research articles cited, policy 
publication date, and so on. A sample breakout search result is illustrated in Figure 3. Note 
the live policy document title, source, and date of posting, as well as the policy publication 
date; the original research article title, source, and publication date; and the weighted 
Altmetric score provided for each original research publication, indicated by the colored 
“wreaths,” or badges. 
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Figure 3. A sample expanded view of an Altmetric output for a United States Preventive 
Services Task Force policy document that cited Pediatrics articles.  
 
 
Once I had isolated and captured the policy mentions for all three sample years of 2010, 
2013, and 2016, I was able to generate three respective .csv files for export. These data pulls 
included article title and original publication date, mention type (“policy document”), policy 
uptake date, policy outlet, policy document title and url, research output title, research source 
(the journal Pediatrics), output type, Altmetric score, article DOI, PubMed ID, and more 
(Figure 4). 
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Figure 4. A sample Altmetric database .csv export.  
 
 
I then used Excel to evaluate the Altmetric data. Not only is Excel compatible with the .csv 
format, but it is a versatile program that allows various forms of sorting, analysis, and 
calculation that were ideal for this investigation. 
 
Data Analysis 
Quantitative Analysis 
The data pull yielded a total of 1110 policy mentions of Pediatrics articles across the three 
sample years. To begin to break the data down, first I verified that the “mention type” was 
“policy document” for all entries, in all three data sets. I also verified that the journal 
Pediatrics was the source of all original articles cited. Second, I scanned through each .csv file 
and identified outputs for which the original publication dates were missing. For these, I had 
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to look up each article on the American Academy of Pediatrics website (aap.org) and plug in 
the publication date, to ensure that I had a full data set to work with. 
 
Once I had finished this task, I searched the spreadsheets for any remaining anomalies. 
Across the three sample years, there were eight outputs for which the original publication 
dates did not resolve with the policy uptake dates (ie, the policy uptake dates occurred before 
the dates of original publication, thus not allowing a calculation of the gap between them). 
These outputs were omitted from the analysis. This discrepancy appeared to be caused by 
the original articles being published online ahead of print, with the policy documents citing 
them in advance of their print date. However, there was no way to know this for certain, and 
a calculation of the gap for these inverse dates was not possible. So, these anomalies were 
eliminated from the data sets, yielding a total of 1102 policy mentions for analysis. 
 
Next, for each mention, I used the Excel “Formulas” function to calculate the gap between 
each individual original publication date and the consequent policy uptake date. When 
creating the formulas, I chose for the results to be calculated in months, instead of years, to 
yield the most specific values possible (when Excel calculates results in years, it provides 
them in whole-year increments, and I wanted partial years to be included, to obtain the most 
accurate results). Next, I created formulas to calculate the mean, median, maximum, and 
minimum values (all in months) to be able to quantify and define the gap within each sample 
year. I then converted these results (in months) to years and partial years (for example, a 
result of 186 months was converted to 15.5 years [186 months/12 months per year = 15.5 
years]). 
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Once I had quantitatively defined the gap per each sample year, I began comparing the 
results between years, to determine whether there were marked differences or similarities 
between them. With my overall quantitative findings in place, I then began my qualitative 
analysis to determine where policy was being cited, by which policymaking organizations, and 
how these organizations related to each other.  
 
Qualitative Analysis 
I began coding each policymaking organization as “U.S.” or “International,” as a preliminary 
means of sorting each mention to begin to determine which policymaking organizations 
cited Pediatrics research articles and whether they were based in the United States or 
elsewhere. Once each entry was coded, I took stock of how many U.S. and International 
mentions there were for each sample year and determined the overall proportions of each. 
Then I began compiling lists of the discrete policymaking organizations that cited Pediatrics 
articles and identifying which ones appeared in the data sets for each sample year. I noted 
similarities and differences between the data sets as I went along. 
 
Since some of the organizations were international, and the names of them appeared in 
languages other than English, I had to research them further to determine whether they were 
different entities from each other, or the same. For example, outputs from the Netherlands 
appeared as “overheid.nl” or “rijksoverheid.nl.” As I investigated each of these outputs, I 
translated the contents of the web pages from Dutch to English, to allow me to discern how 
they related to each other. In this case, “rijksoverheid.nl” is the site for the National 
Government for the Netherlands, and “overheid.nl” represents an initiative of the Ministry 
of the Interior and Kingdom Relations in the Netherlands. I noted these findings and the 
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relationships between the entities, as I considered how to subcategorize the policymaking 
bodies cited. 
 
With the organizations generally mapped out, I then began to research each individual 
policymaking body one by one, to decide how to further subcategorize the data sets. For 
example, the World Health Organization and the Food and Agriculture Organization of the United 
Nations are both agencies of the United Nations, which distinguished them from the other 
types of policymaking organizations—so these were assigned their own subcategory. 
 
When I had finished researching each organization, I was able to cluster the organizations 
into the most specific subcategories I could identify—which yielded a total of nine 
subcategories. I then amended the original “International” and “U.S.” codes assigned to 
elucidate the following nine subcategories:  
 
(a) International Government: A policymaking body of a foreign (non-U.S.) government 
 
(b) International Organization: A non-government-based international policymaking body  
 
(c) International Government-Funded Organization: A foreign (non-U.S.) policymaking 
organization funded by a foreign government but not a part of the government itself 
 
(d) U.S. Government: A policymaking body of the United States government 
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(e) U.S. Charter: A U.S. policymaking organization chartered by the United States Congress 
 
(f) International Government-Funded Banking Cooperative: An international government-
funded banking coalition that establishes policy and provides development financing to 
countries 
 
(g) Agency of the United Nations: A policymaking body of the United Nations 
 
(h) International Nonprofit Organization: A foreign (non-U.S.) nonprofit policymaking body 
 
(i) U.S. Nonprofit Organization: A U.S.-based nonprofit policymaking body 
 
The clustering of organizations into subcategories is detailed in the Results section. 
 
After all entries were fully coded and subcategorized within each sample year, I then 
combined the data for all three sample years and began defining the know-do gap both as a 
whole and according to each subcategory. I used the Excel Formulas function to find the 
mean, median, maximum, and minimum values for each subcategory and compared and 
contrasted the results between each. On the basis of the ranges in values, I then began 
breaking the gap out into 5- and 10-year increments and tallying how many mentions 
appeared within each time frame, to more closely pinpoint the time at which Pediatrics articles 
were cited in policy and how this was the same or different between policymaking bodies. 
This allowed me to “crack open” the cumulative gap and reveal how the know-do gap in 
pediatrics may truly be characterized. 
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This strategy constituted the limits of my focused investigation. I did not examine how the 
Pediatrics articles were used in the policy documents, for example, since there were thousands 
of mentions in policy documents, and I would have had to research each one individually. I 
restricted my analysis to defining and assessing the gap between the original publication of 
research and its eventual uptake in policy. 
 
By the time I was finished analyzing the data, I had examined the gap from a number of 
different angles, broken out and combined in many different ways, to illustrate what the gap 
in pediatrics looked like not only as a whole, but also across and among the various 
landscapes of different countries, agencies, and funding sources.  
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CHAPTER 4 
RESULTS 
The policy mentions of Pediatrics articles identified with the Altmetric tool allowed patterns 
to be identified and definitive conclusions to be drawn about the knowledge translation gap 
in pediatrics. The mixed-methods approach permitted my quantitative findings to be nested 
within a more qualitative context; the results are presented herein. When discussing the 
results of this investigation, the mean is defined as the central tendency of the data, the median 
is defined as the midpoint of the distribution, the minimum is defined as the smallest value in 
a data set, the maximum is defined as the largest value in a data set, and the range is defined as 
the minimum to maximum values. 
 
 
Quantitative Findings 
The total number of Pediatrics policy mentions available for analysis included 246 mentions 
for the year 2010, 363 mentions for the year 2013, and 493 mentions for the year 2016, for a 
grand total of 1102 mentions. The mean knowledge translation gap was 6.0 years for 2010, 
7.3 years for 2013, and 7.6 years for 2016. The gap ranged from 0 to 32.8 years across all 
policy mentions, and the median gap ranged from 5.3 to 7.0 years across the three data sets 
(Figure 5).  
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Figure 5. The mean, median, and maximum gap for each sample year of 2010, 2013, 
and 2016. 
 
 
 
U.S. Versus International Results 
When the policy mentions were classified according to U.S. versus international mentions, 
there were more international policy mentions of Pediatrics articles than there were U.S. 
mentions, with 593 international policy mentions and 509 U.S. policy mentions (Table 1). 
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Table 1. Number of U.S. Versus International Policy Mentions 
Sample Year Total No. of 
Pediatrics 
Mentions 
International Policy 
Mentions 
U.S. Policy 
Mentions 
2010 246 137 (55.7%) 109 (44.3%) 
2013 363 177 (48.8%) 186 (51.2%) 
2016 493 279 (56.6%) 214 (43.4%) 
Total 1102 593 (53.8%) 509 (46.2%) 
 
 
When the gap was calculated between international and U.S. policy mentions, the mean gap 
for international policy uptake was 7.6 years, whereas the mean gap for U.S. policy uptake 
was 6.6 years. Therefore, even though more Pediatrics articles were cited in international 
policy than in U.S. policy, the findings showed that the research information made it through 
the knowledge translation process more quickly in the United States than it did in the rest of 
the world (Table 2). The range of the gap was also wider in the United States than it was for 
the rest of the world, with lower minimum values and higher maximum values. 
 
 
Table 2. The Gap Between International and U.S. Policymaking Organizations 
Policymaking 
Location 
No. of 
Mentions (n = 
1102) 
Range (years) Mean (years) Median 
(years) 
United States 509 (46.2%) 0-32.8 6.6 5.8 
Other countries 593 (53.8%) 0.5-25.0 7.6 7.0 
 
 
 
  43 
The Overall Gap 
When the overall (combined) gap was tabulated across all sample years and all policy 
mentions, the mean gap was 7.1 years, with a median of 6.5 years. To further characterize 
what the gap looked like overall and between U.S. and international policy mentions, I 
stratified the mentions according to 5- and 10-year increments to be able to compare and 
contrast them.  
 
Interestingly, only 0.4% of Pediatrics articles were cited in policy 20 years or more after the 
time of original publication, and fewer than one-quarter of articles were cited in policy 10-20 
years after original publication. More than three-quarters of Pediatrics articles took fewer than 
10 years to achieve uptake in policy (Figure 6). 
 
 
 
 
 
Figure 6. The overall gap according to 10-year increments. 
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Further Gap Characterization 
When I broke the data out further, I found that not only were the vast majority of articles 
cited less than 10 years after publication, but in fact, nearly 40% of articles were cited fewer 
than five years after publication (Table 3).  
 
 
Table 3. The Overall Gap According to Five-Year Increments 
Time Interval No. of Policy Documents (n = 
1102) 
Percentage 
20+ years 4 0.4% 
15-20 years 59 5.4% 
10-15 years 204 18.5% 
5-10 years 403 36.5% 
0-5 years 432 39.2% 
 
 
 
 
When I tallied how many Pediatrics articles took 1 year or less to reach the point of policy 
uptake (mentions of articles in policy), I found that across all years, 8.2% of U.S. policy 
mentions reached policy uptake in 1 year or less, whereas 1.2% of international policy 
mentions reached policy uptake in 1 year or less. This represented a marked difference 
between U.S. and international policy mentions. When the two categories were combined, a 
total of 4.5% of articles were cited in 1 year or less, across all policy mentions. 
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Regarding trends in the gap between U.S. and international policy, 80% of Pediatrics articles 
were cited in U.S. policy within 10 years after original publication (Figure 7), and 45% of 
articles were cited in U.S. policy within 5 years (Table 4, Figure 8).  
 
 
 
 
 
Figure 7. The U.S. gap according to 10-year increments. 
 
 
 
 
 
Table 4. The U.S. Gap According to Five-Year Increments 
Time Interval No. of Policy Documents (n = 
509) 
Percentage (%) 
20+ years 2 0.4% 
15-20 years 22 4.3% 
10-15 years 76 14.9% 
5-10 years 179 35.2% 
0-5 years 229 45.0% 
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Figure 8. The U.S. gap according to five-year increments (509 policy documents). 
 
 
 
 
In international policy mentions, 27.6% of Pediatrics articles were cited between 10 and 
20 years after original publication, with the vast majority (71.8%) cited 10 years or less 
after original publication (Figure 9). A total of 34.1% of international policy mentions 
occurred within 5 years of original publication. 
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Figure 9. The international gap according to 10-year increments. 
 
 
 
When the international gap was further characterized, the most noteworthy difference 
with U.S. policy mentions is that while the majority of U.S. mentions occurred in policy 
documents in 5 years or less, this was not the case with international mentions. Most 
international mentions (37.8%) required 5 to 10 years to make it through the process of 
knowledge translation (Table 5, Figure 10). This is consistent with the finding of 
slightly longer mean and median uptake times for Pediatrics research cited in international 
policy. 
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Table 5. The Gap for International Policy According to Five-Year Increments 
Time Interval No. of Policy Documents (n = 
593) 
Percentage (%) 
20+ years 2 0.3% 
15-20 years 36 6.1% 
10-15 years 128 21.6% 
5-10 years 224 37.8% 
0-5 years 202 34.1% 
 
 
 
 
 
 
 
Figure 10. The international gap according to five-year increments (593 policy 
documents). 
 
 
 
It is not known why the research took slightly longer to reach the point of policy uptake 
in international policy than in U.S. policy. 
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Qualitative Findings 
 
A total of 22 policymaking bodies cited Pediatrics policy, comprising 16 international 
organizations and eight U.S. organizations. The international bodies were from the United 
Kingdom, the Netherlands, Germany, and Australia and included international government-
funded cooperatives that have memberships of up to 189 countries worldwide (World Bank, 
2018). The organizations represented a wide swathe of policymaking bodies around the 
globe, from governments to the European Union. The individual organizations that cited 
Pediatrics articles in their policy for each sample year are provided in Table 6. 
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Table 6. Policymaking Organizations That Cited Pediatrics Research, by Sample 
Year 
Policymaking Organization 2010 Policy 2013 Policy 2016 Policy 
The U.S. Centers for Disease 
Control and Prevention 
X X X 
The World Health Organization X X X 
The Government of the United 
Kingdom 
X X X 
The United Kingdom National 
Institute for Health and Care 
Excellence 
X X X 
The Australian Government X X X 
The United States Preventive 
Services Task Force 
 X X 
The National Government for 
the Netherlands 
X X X 
The Scottish Intercollegiate 
Guidelines Network 
X X X 
The National Academies Press X X X 
The World Bank X X X 
The Association of the Scientific 
Medical Societies in Germany 
X X X 
The Mental Health Foundation  X X 
The United Kingdom Parliament   X 
The European Union 
 
  X 
The European Food Safety 
Authority 
X X  
The American Speech-Language-
Hearing Association 
 X  
The Food and Agriculture 
Organization of the United 
Nations 
  X 
Overheid, An Initiative of the 
Ministry of the Interior and 
Kingdom Relations in the 
Netherlands 
 X X 
The World Economic Forum   X 
The Inter-American 
Development Bank 
  X 
The National Bureau of 
Economic Research 
X X X 
The Brookings Institute X X  
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The organizations were coded according to their location, type, and funding sources and 
were ultimately classified as belonging to one of nine subcategories. The resultant 
subcategorization structure is presented in Table 7. 
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Table 7. Finalized Clusters of Policymaking Organizations for Coding Purposes 
Subcategory Policymaking Organization 
International 
government 
The Government of the United Kingdom 
The United Kingdom Parliament 
The United Kingdom National Institute for Health and 
Care Excellence 
The Australian Government 
The National Government for the Netherlands 
Overheid, An Initiative of the Ministry of the Interior and 
Kingdom Relations in the Netherlands 
U.S. government The U.S. Centers for Disease Control and Prevention 
The United States Preventive Services Task Force 
Agency of the United 
Nations 
The World Health Organization 
The Food and Agriculture Organization of the United 
Nations 
International 
organization 
The European Union 
The European Food Safety Authority 
The Association of the Scientific Medical Societies in 
Germany 
International 
government-funded 
organization 
The Scottish Intercollegiate Guidelines Network 
Charter of the U.S. 
government 
The National Academies Press 
International 
government-funded 
banking cooperative 
The World Bank 
The Inter-American Development Bank 
International 
nonprofit organization 
The Mental Health Foundation 
The World Economic Forum 
U.S. nonprofit 
organization 
The American Speech-Language-Hearing Association 
The National Bureau of Economic Research 
The Brookings Institute 
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The number of Pediatrics mentions in policy created by each subcategory was tallied, and 
the results appear in Figure 11. Since there were so few mentions for nonprofit 
organizations, the U.S. and international nonprofit organizations were combined for the 
purposes of visual presentation. 
 
 
 
 
Figure 11. The number of Pediatrics policy mentions released by each policymaking 
subcategory. 
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The most mentions came from organizations chartered by the U.S. government, 
followed by international governments and agencies of the United Nations. With only 
one organization in the U.S. charter category, this means that one single body (the 
National Academies Press) was responsible for more mentions than any other category 
(315 mentions). The National Academies Press was created by a U.S. Congressional 
charter to advise the federal government on matters of national importance and urgency, 
regarding questions of health policy, science, and technology (The National Academies 
Press, 2018)—so it is a highly active policymaking organization. 
 
The international governments that used Pediatrics research in their policy included the 
United Kingdom government and Parliament, the National Government for the 
Netherlands, and the Australian government. The fewest mentions came from the 
international government-funded banking cooperatives and the nonprofit organizations, 
both in the United States and abroad. 
 
The mean and median knowledge translation gap for each subcategory appear in Figure 
12. Interestingly, the international government-funded banking cooperatives had the 
shortest knowledge translation gap of the nine subcategories, at 4.0 years. International 
nongovernment organizations had the second shortest gap at 5.9 years, with 
international government-funded organizations having the longest gap, at 8.7 years. 
However, the mean and median gap across all subcategories were still notably under 10 
years for all organization types (Figure 12). 
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Figure 12. The mean and median gap for each policymaking subcategory. Of note, all values 
are under 10 years. 
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CHAPTER 5 
DISCUSSION 
Answering the Research Questions 
Research Question 1: What is the specific knowledge translation gap between original research publication in 
the journal Pediatrics and its eventual uptake in policy? 
The data in this study were analyzed a number of ways, and the overall (combined) gap for 
Pediatrics research moving through the knowledge translation model was under 10 years from 
every analytical angle, with a mean gap of 7.1 years and a median gap of 6.5 years. The gap 
for Pediatrics research therefore came in at significantly less than one-half of the 17-year 
average reported in the literature for each sample year. This was an unexpected finding, since 
the literature provided a clear expectation of a gap of up to 20 years, and sometimes more 
(Green, Ottoson, García, & Hiatt, 2009; Clancy, Glied, & Lurie, 2012; U.S. Department for 
Health & Human Services, 2001; Dingfelder & Mandell, 2011). The methods previously used 
to define the gap were not reported, however, so it is difficult to pinpoint what evidence was 
used to arrive at these earlier estimates, and how it was used. In my study, it is noteworthy 
that only 0.4% of Pediatrics articles were cited in policy 20 years or more after the time of 
original publication. 
 
Since median values can sometimes provide a better measure of central tendency than the 
mean, as they are less influenced by outliers such as the 0.4% that occurred in my study, I 
included median values in my analysis to reduce the sensitivity to outliers and to be able to 
characterize the gap as fully and as accurately as possible. This is another reason I stratified 
the gap according to 5- and 10-year intervals, to be able to pinpoint and describe it more 
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carefully, instead of relying on general, “umbrella” findings alone, and the pitfalls that 
accompany them. It is worth noting that the 20-year knowledge translation gap described in 
the literature wound up representing only a handful of outliers in my Altmetric analysis. 
 
Research Question 2: Is this knowledge translation gap the same between sample years of policy, or is it 
variable? 
Whether looking at mean or median values, the gap for the sample years of 2010, 2013, and 
2016 was surprisingly uniform. The only variance was from median values of 5.3 to 7.0 years 
and from mean values of 6.0 to 7.6 years across the three data sets. Given the fact that the 
cumulative range totaled 0 to 32.8 years, the small variance between mean and median values 
across sample years was surprisingly slim. The relative consistency across values and 
analytical angles implies that there are mechanisms in place that affect and perpetuate the 
gap, outside of any sample-based considerations. I discuss these potential mechanisms and 
other contributing factors later in this chapter. 
 
Research Question 3: Are there differences or no differences in this gap among the various policymaking 
organizations that use Pediatrics research evidence? 
Although there were more international mentions than U.S. mentions, and although U.S. 
mentions appeared more quickly than the international mentions did on the whole, there 
were no drastically different findings among the gaps between the different categorizations. 
Even when the gap for various policymaking subcategories was probed for differences 
between groups, Figure 12 demonstrates that the mean and median gap were largely 
consistent between policymaking bodies, with all cumulative results coming in under 10 
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years and most residing between 5 and 10 years. The international government-funded 
banking cooperatives were admittedly an outlier at 4.0 years. However, this was also 
coincidentally the group with the fewest mentions, so these data may be not be a true 
reflection of this category, had there been more mentions available for analysis. Either way, 
it is remarkable that nearly half of all Pediatrics articles were cited in U.S. policy within 5 years 
of original publication. 
 
Immediate Implications 
Since the knowledge translation gap in pediatrics turned out to be quite different than the 
gap reported in the literature, I had to take a step back from the data and ask, “What does 
this mean?” and “How did this happen?” Since there were no specific methods discussed in 
previous reports for me to compare against my own, I had to instead consider what may 
have changed since these prior analyses of the gap were performed, to surmise what could 
have reduced the gap so drastically. I also had to take into account that previous reports 
were not pediatric in focus, but were general estimates in biomedicine. In the end, I was able 
to identify several possible contributing factors. 
 
First, it seems likely that the online environment in which biomedical articles are now 
published and exchanged may allow policy and practitioner uptake to occur more rapidly 
than was possible prior to the advent of electronic publishing—particularly regarding the 
early online release of research articles, before they appear in print. The enhanced online 
connectivity of researchers, policymakers, and practitioners, as well as the accessibility and 
searchability of articles being made available online today, may significantly reduce the 
amount of time it takes for research to make it through the knowledge translation process. 
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The fact that eight of the original policy mentions pulled from the database were cited before 
publication of the original article would appear to point toward this explanation. While there 
is no way to assert this definitively, it may play a part. 
 
Second, the results would seem to indicate that the knowledge digestion activities of brokers 
in health communications—in this case, the brokers involved with the journal Pediatrics at the 
American Academy of Pediatrics—do help facilitate the uptake of critical research evidence 
into policy and practice. For example, when reviewing their research presentation practices, I 
found that Pediatrics takes the extra step of publishing a brief summary with each research 
article, detailing “what is already known” on the subject and “what the research study adds” 
to the knowledge base. This reporting practice began in 2009, in an effort to help 
practitioners and policymakers identify the most important findings presented in each article. 
In the future, it would be an interesting line of study to determine what the gap for Pediatrics 
looked like, before and after this policy-friendly reporting practice was adopted in 2009. 
 
Research dissemination is not a single or a simple process, and much effort has gone into 
improving it (UNICEF, 2008). Over the past 10 to 15 years, there has been increasing 
international attention placed on how to reduce the gap between evidence, policy, and 
practice (Grimshaw et al, 2012). Indeed, the direct form of summarization adopted by the 
journal Pediatrics succinctly fulfills the needs and requests of policymakers and practitioners, 
who have been clamoring since the early 2000s for research results that are spelled out for 
them in plain language (Feldman et al, 2001; Sorian & Baugh, 2002). For this reason, and as 
evidenced by the expedited process of knowledge translation uncovered in my study, it can 
be inferred that taking the extra step of “translating” research findings for policymakers and 
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practitioners really can have a direct and marked impact on the know-do gap. If the 
brokerage effects in this field were ineffectual, then this would be reflected in the data. 
However, since the overall gap of 7.1 years for Pediatrics research constitutes a fraction of the 
gap reported for the biomedical literature, it would seem that the journal Pediatrics may be 
doing something right—and can potentially serve as an example of how successful brokerage 
activities can help narrow the know-do gap in medicine. 
 
Another potential implication is that the methods used to calculate the gap in previous 
studies are now out of step with current communication practices—particularly electronic 
publishing and the release of research articles online, ahead of print. It is possible that 
previous calculations of the biomedical research-practice gap were undertaken prior to the 
advent of the electronic platform that has now subsumed scientific reporting, and that the 
gap has metamorphosed in a relatively short amount of time. This metamorphosis may in 
turn radically change the role and applicability of methods such as traditional citation analysis 
in tracking the impact of research evidence going forward; new methods may be needed to 
help define and understand the gap as it stands today. Now that revolutionary tracking 
resources such as altmetrics are becoming available, it may be possible to redefine the gap 
more accurately and quickly than before, across and between subspecialties in medicine 
(Wouters & Costas, 2012; Bornmann, 2014; Citrome, 2015). 
 
Perhaps most importantly, the results would seem to suggest that the requests policymakers 
and practitioners make for the thoughtful presentation and digestion of research evidence do 
have a direct impact on the uptake of research for policy and practice. Based on the 
substantial number of Pediatrics articles that were cited in policy up to 5 years after 
  61 
publication (39.2%)—which is less than one-third of the 17-year gap cited in the literature 
(Green, Ottoson, García, & Hiatt, 2009)—it appears that these reporting practices can have 
a positive effect on uptake times. Indeed, Huston (2008) maintains that research is the most 
likely to get attention when it informs realistic policy actions. In this way, well-translated 
synthesis activities can help policymakers see clear links between research findings and 
policymaking solutions by distilling out unnecessary “noise.” 
 
Finally, the longest uptake times after original publication in my study were 32.8 years, 26.9 
years, and 25.0 years. All other policy mentions occurred less than 25 years after original 
publication, and most came in significantly under this. Outliers such as these may reflect the 
phenomenon that in some cases, the research may need time to mature, with extreme cases 
being called “sleeping beauties”—articles that can remain uncited for decades, before their 
worth is discovered (Rasmussen & Andersen, 2013; Van Raan, 2004). Further analysis would 
be required to determine whether this was the case here. 
 
This last finding also illustrates the fact that just because a study is more than a few years old 
does not mean that it is not relevant or does not have a place in policymaking decisions 
being made today. As shown here, some studies may add value even many years after their 
original publication. This fact alone should give biomedical researchers hope that their 
findings may yet have value and may still contribute to improved patient outcomes, even if 
their research takes time to incorporate into the knowledge base. It was beyond the scope of 
this study to discern whether different study types have different uptake times, but this 
would be an interesting avenue of study for future evaluation. 
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Broader Implications for Technical Communicators 
Research does and should influence policy (Clancy, Glied, & Lurie, 2012). However, much 
emphasis is often placed on generating and funding research, while less emphasis is placed 
on informing the real-world solutions that research can help provide. This is unwise, as 
Lewis (2007) states that “unassembled” research findings almost never address the broad 
dilemmas that confront clinicians and policymakers. In the same vein, Feldman et al (2001) 
demonstrated a mismatch between the needs of policymakers and the activities of 
researchers and explained that researchers, funders, and others who hope to maximize the 
use of research information must recognize this reality. The more this “mismatch” can be 
addressed and rectified—especially by the dedicated efforts of knowledge brokers (technical 
communicators)—the more useful research findings will become in the world of policy and 
practice. 
 
Knowledge brokers know that the creation of research that is ignored by policymakers and 
practitioners results from not understanding good dissemination practice. There can be a 
lack of motivation on the part of researchers to translate their findings into policy-relevant 
terms and disseminate them, as well as a lack of resources to support these efforts (Clancy, 
Glied, & Lurie, 2012). This is where the value of the knowledge broker truly lies. 
Policymakers and practitioners have to be convinced that a proposed intervention will work 
in the real world and not only in a laboratory or an academic environment. Knowledge 
brokers can not only identify the needs of policymakers and practitioners, but they can work 
with researchers to make sure that these needs are met. Indeed, knowledge brokers may be 
the key players in ultimately reducing the know-do gap in biomedical reporting. 
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Many argue that researchers have an obligation to get involved in policy development; in 
fact, the ethics guidelines of the American College of Epidemiology call on epidemiologists 
to “report research findings in a timely, understandable, and responsible manner so that the 
widest possible community stands to benefit” (Brownson, Royer, Ewing, & McBride, 2006). 
Because scientific knowledge changes over time—particularly in biomedicine—forward 
advancement requires critical interpretation of empirical findings, evolution of qualitative 
and quantitative synthesis methods, and improvement in research practice and reporting 
(Anderson et al, 2005). In this setting, knowledge exchange is the new frontier of bringing 
research to policy and practice (World Health Organization, 2004), and technical 
communicators serve on the front lines. 
 
Policymakers emphatically want information that is presented simply, with clear graphics and 
findings, that can be used without alteration (Feldman, Nadash, & Gursen, 2001), and 
knowledge brokers can help provide this. Additionally, policymakers have an immediacy in 
their need for information (Greenlick, Goldberg, Lopes, & Tallon, 2005), which knowledge 
brokers should be sensitive to in their dissemination efforts. Products that meet these 
requirements are valued and are actually used (Feldman, Nadash, & Gursen, 2001).  
 
Most importantly, to make their work more usable and understandable, researchers must 
help facilitate the application of their results in policy actions and practice. Knowledge 
brokers can assist researchers in this capacity. Effective communication can speed up the use 
of research findings in practice (World Health Organization, 2004), so it is critical that 
researchers communicate their findings clearly to be able to translate health services research 
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into policy (Greenlick, Goldberg, Lopes, & Tallon, 2005). It is the role of the knowledge 
broker to ensure that this happens effectively and expediently. 
 
Simply producing rigorous and precise results about an important problem is not enough for 
a piece of research to have a broader impact (Clancy et al, 2012). Dissemination events need 
to be tailored to the target audience and evaluated (Sorian & Baugh, 2002), and a 
combination of dissemination methods should be used to share research summaries 
(UNICEF, 2008). This is the specialty of the technical communicator. Within biomedical 
communications, research on ways to improve knowledge transfer and access in health 
systems should be a priority and should address the major barriers of language skills, 
financial constraints, and quality of scientific publications (World Health Organization, 
2004). Ultimately, what the results of this study may prove is that policymakers are more 
likely to use research if its implications for policy are clearly spelled out for them, as is being 
done in the journal Pediatrics. When research is made accessible to policymakers, it results in 
expedient and meaningful policy development—and in this scenario, everyone wins. 
 
Successful Brokering Efforts 
The markedly reduced gap for the research published in the journal Pediatrics would seem to 
indicate that Pediatrics is successfully digesting its research content for effective policy and 
practitioner uptake, and this is likely expedited by the release and exchange of research 
findings via the electronic environment. It is apparent from the presentation of their 
research reporting methods that a concerted effort is being made to highlight and 
disseminate their findings with the policymaker and end user in mind. In other words, they 
are demonstrating their responsiveness to the needs of policymakers and practitioners by 
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adjusting their reporting practices over time. This is especially needed in the field of 
pediatrics because pediatricians are generalists who represent a patient population that has 
much less agency than others; therefore, they often intersect with public health in ways that 
no other subspecialty in medicine does. Within the efforts knowledge brokers are making to 
close the know-do gap in biomedicine, much can be learned from the approach of Pediatrics 
to knowledge translation and dissemination. 
 
Organizations cited as being effective information brokers are those that see good 
dissemination as the product of sound data and are able to dedicate money and staff for the 
purposes of information synthesis, translation, and dissemination (Feldman, Nadash, & 
Gursen, 2001). Academic journals are increasingly taking an active role in the translation of 
the research that they publish (Thoma, Mohindra, Artz, & Chan, 2015). For instance, it is 
becoming widely acknowledged that every journal article should be accompanied by a single-
page policy piece that states the implications of the research in language that laypeople can 
understand (Greenlick, Goldberg, Lopes, & Tallon, 2005; Sorian & Baugh, 2002). 
 
In 2017, a longitudinal study of pediatricians showed that they prioritize staying up to date 
on the latest medical knowledge. They often catch up on work at home, and they stay 
apprised on how the debate over health care policy affects their patients and their practice 
(American Academy of Pediatrics, 2017). This may be attributed to some degree by the fact 
that as part of their bridging efforts, the American Academy of Pediatrics organizes more 
than 28 national committees,  52 sections, 13 councils, and 66 chapters in both the United 
States and Canada to help mobilize members and get them involved with children’s health 
care initiatives at all levels of the knowledge translation process (American Academy of 
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Pediatrics, 2018). Their active brokerage efforts almost certainly affect the level of interest 
and involvement reflected in their constituency, which contributes to increased participation 
in a more circular and effective knowledge translation model. 
 
Indeed, through policymaking efforts, educational programming and resources, advocacy for 
children’s health initiatives, and the active translation of policy and education into practice, 
these activities involve the interaction of practitioners and researchers, coming together to 
solve health problems. In other words, what the current findings may truly show is what is 
possible and attainable if knowledge brokers embrace the principles of a nonlinear, circular 
knowledge translation system and use it to bring members on both sides of the gap together 
to enact solutions. What the results of my study unwittingly revealed is, effectively, a success 
story. 
 
What Technical Communicators Can Do 
Going forward, a strong emphasis should be placed on improving the linkages between 
researchers and policymakers—including the need for developing a network of knowledge 
brokers and other intermediaries to support decision making for policy and practice (World 
Health Organization, 2004). Science must help to improve health systems, and not merely be 
conducted for its own sake. Research should not only be a “quest for understanding”—it 
should also involve considerations of use (Huston, 2008), and its findings should be bundled 
with policymaking and practitioner needs in mind. The overall gap of 7.1 years for the 
research published in the journal Pediatrics embodies the successful results of these efforts. 
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While scientific knowledge can be used to inform the creation and implementation of policies 
and practice decisions, undigested information is unlikely to have any effect. As such, 
communications efforts must be directed toward bridging the professional, cultural, and 
linguistic divide between researchers, policymakers, and practitioners. Bringing researchers 
and policymakers together can help to make researchers’ work more relevant by exposing 
researchers to real-world problems to which their skills and insights can be applied. To 
integrate new evidence into practice, researchers and practitioners must work together 
(Olswang & Prelock, 2015), and knowledge brokers can make this happen by facilitating 
communication in both directions. After all, biomedical discoveries cannot improve people’s 
health without discerning how they may be applied within diverse populations, health 
systems, and political and social contexts (World Health Organization, 2004). This is the 
bread and butter of the technical communicator. 
 
Initiatives created specifically to facilitate high-quality knowledge translation and 
dissemination include journals, conferences, podcasts, systematic reviews, and evidence-
based clinical practice guidelines. Additionally, professional communicators may rely on 
policy briefs, reports, newsletters, one-on-one communications, academic journals, meetings, 
Web content, and other methods to facilitate the digestion of research (Feldman, Nadash, & 
Gursen, 2001). New structures and means of translating knowledge into effective 
interventions should also be identified. For instance, more research syntheses should be 
undertaken on health problems with the highest global burden (World Health Organization, 
2004), as well as determining what brokerage efforts are needed to alleviate these pain 
points. The care of children most definitely falls into this category. 
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Because science tends to be compartmentalized, with each subspecialty possessing its own 
culture, language, and funding streams, it is a worthwhile endeavor to obtain a current 
snapshot of the knowledge translation gap within each individual subspecialty in 
biomedicine. I hope this study serves as an example of what kinds of insights may be 
revealed by doing so. I would encourage other technical communicators to conduct similar 
studies, to determine what the current gap looks like in their own subspecialties. Since 
children are a medically and ethically unique and habitually underserved constituency, 
discovering what the know-do gap in pediatrics actually looks like, instead of what may be 
surmised in a general way from the literature, can only help to drill down the enormous 
efforts currently underway on national, international, and local levels, to expedite the uptake 
of valuable pediatrics research. Studies like this one should be undertaken to evaluate the 
uptake for other pediatric journals and content, as well, to determine if the findings here are 
representative of the entire field, or only of this journal. If it is discovered that the gap for 
Pediatrics research is significantly less than that for other pediatric research outlets, then 
perhaps other organizations and brokerages can learn from what the American Academy of 
Pediatrics is doing successfully. 
 
At the end of the day, knowledge is not a commodity—it does not effortlessly flow down a 
linear gradient, from researchers to decision makers, like a swiftly flowing stream. Efforts 
must be made on the part of all stakeholders to usher the knowledge forward. If we relate 
knowledge to the interplay of a soccer game, knowledge is not the soccer ball; rather, it is 
what goes on between the players—those who share a belief and a common purpose of moving 
the ball into the goal (World Health Organization, 2004). Therefore, what each player is 
doing on the field is critical to the unfolding of the game. To improve the uptake of evidence 
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in policy and practice, developing better ongoing interaction between the players—the 
evidence providers, the evidence users, and the technical communicators who facilitate 
passing the ball—is the way forward (UNICEF, 2008). 
 
Limitations 
This study had a few limitations. It is likely that more countries cited Pediatrics research in 
their policy than were actually identified by the Altmetric search. Because the Altmetric 
platform continues to evolve, it is probable that health policies released by additional 
countries will be tracked in the Altmetric database in the future. This would have the added 
benefit of generating greater numbers of mentions for analysis. Since three years’ worth of 
policy were selected for evaluation in this study, it is also possible that sampling additional 
years could alter the current findings; however, this seems unlikely, since the gap was 
essentially so consistent across the board. There may be other types of policymaking 
organizations that were not tracked with this database to date, as well, which may be added 
to the Altmetric database in the future. Additionally, it is not known whether other research 
outlets in pediatrics would see the same knowledge translation gap for their materials as the 
journal Pediatrics does—it is possible that their research reporting practices are different, and 
may yield different results. Further study would be required to determine if this is the case. A 
final limitation is that this study did not include an analysis of how Pediatrics articles were 
used in each individual policy documents. This might provide a fruitful avenue for further 
study, as well. 
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Conclusion 
At 7.1 years, the mean gap between what is known from research published in the journal 
Pediatrics and what is actually being used is significantly less than what has been reported in 
the literature to date. This is welcome news. Furthermore, the alternative impact measures of 
the Altmetric platform made this analysis possible and may allow additional and more 
comprehensive analyses to be conducted, to find out how knowledge brokers are really 
doing in their efforts to narrow the gap in medicine. Going forward, given the huge potential 
to save the lives of millions of children and improve the health of many more, implementing 
critical knowledge brokerage efforts to promote the use of evidence-based interventions 
should be a priority for researchers, policymakers, practitioners, and society in general. 
Members on both sides of the “know-do divide” see great potential for improved 
communication, which will lead to better uses of research information (Feldman, Nadash, & 
Gursen, 2001)—and technical communicators can help make this happen. For children and 
families everywhere, it could make all the difference. 
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